Bangkok Heart Hospital
 
 Friday, December 1, 2006    
 8.00 a.m. – 3.00 p.m.  Registration Open
 11.00 a.m. – 11.10 a.m.  Welcome: Kitipan Arom, Program Chair
 Opening Remark: General Surayud Chulanont, Prime Minister of  Thailand
 
 11.10 a.m. – 12.10 a.m.  Lunch Symposium I
 Chair: Doris A. Taylor & Lertlak Chaothawee
 - Ensuring the Safety of Human Stem Cell in Clinical Applications
   Alan
Smith, Cognate BioServices, Baltimore, MD, USA
 - Business Strategies for Bringing Stem Cell Therapies from the Lab
   to the Bedside: Lessons Learned from Company  Successes and
   Failures  to Date
   Linda
Powers, Toucan Capital Fund II, USA
 
 12.10 p.m. – 4.00 p.m.  Plenary Session I : Cell Therapy: Heart Failure and Basic Science  of  Cardiac Stem Cell
 Chair: Doris A. Taylor & Suradej Hong-Eng
 
 12.10 p.m.  Cell Therapy for Heart Failure: Muscle, Bone Marrow, Blood, and  Cardiac-Derived Stem Cells
 Doris A.
Taylor, University of  Minnesota, Minneapolis, MN, USA
 
 12.30 p.m.  Xenogeneic/Allogenic Cell Transplant
 Ray J. Chiu
, McGill  University, Montreal, Canada
 12.50 p.m.  Embryonic Stem Cell
 Richard D. Weisel,
Toronto General Hospital, Toronto, Canada
 1.10 p.m.  Adult Bone Marrow-Derived Angioblasts and Mesenchymal Stem Cell  Silviu Itescu, Columbia University, New York, USA
 1.30 p.m.  Discussion
 1.50 p.m.  Coffee Break
   Chair: Silviu Itescu & Taweesak Chotivatanapong
 2.10 p.m.  Endothelial Progenitor Cells: From the Recovery to Present  Takayuki Asahara, RIKEN Center for Developmental Biology, Kobe,  Japan
 2.30 p.m.  Umbilical Cord Blood Derived CD 133 + Hematopoietic Stem Cells
 Mary Laughlin, Case  Western Reserve University, Cleveland, OH,  USA
 2.50 p.m.  Myoblast Transplantation for Heart Repair: A Review of State of the  Field
 Kristin Comella,
Bioheart Inc., Sunrise, FA, USA
 3.10 pm  Myocardial Infarction: from Reperfusion to Regeneration of  Myocardial Tissue              
 Frans Van de Werf
, University Hospital Gasthuisberg, Leuven,         Belgium
 3.30 pm  Discussion
 4.00 pm  Adjourn
             
 Saturday, December 2, 2006      
 7.00 a.m. – 7.50 a.m.  Breakfast Symposium I
 Chair: Eugene
Sim & Jongjate  Aojanepong  

 Granulocyte Colony Stimulating Factor
 Kostas I.
Papadopoulos, StemLife, Bangkok, Thailand
 
 9.00 a.m. – 3.00 p.m.  Registration Open
 7.50 a.m.  Announcement
 8:00 a.m. - 10.00 a.m.  Plenary Session II: Cardiac Assessment and Angiogenesis  Chair: Masashi Komeda & Gumpanart Veerakul
 8.00 a.m.  Cardiac MRI: What We Have Learned from MRI in Stem Cell  Therapy?
 Lertlak Chaothawee
. Bangkok Heart Hospital, Bangkok, Thailand
 
 8.20 a.m.  Novel Methods for Infarct and Perfusion Imaging
 Samart Rajchanada
, Bangkok Wattanosoth Hospital, Bangkok,  Thailand
 
 8.40 a.m.  What are the Next Best Combinations When the CMR Can Not Be  Utilized?
 Rungroj Krittayaphong,
Siriraj Hospital, Bangkok, Thailand
 
 9.00 a.m.  Angiogenesis for Coronary Artery Disease
 Eugene Sim,
National University Singapore, Singapore
 9.20 a.m.  Therapeutic Angiogenesis by Growth Factor
 Masashi Komeda
, Kyoto University, Japan
 9.40 a.m.  Angiogenesis Induced by Cell Transplantation
 Ren-Ke Li,
Toronto General Hospital, Toronto, Canada
 10.00 a.m.  Coffee Break
 10.20 a.m.-12.20 p.m.  Plenary Session III : From Basic Science to Bedside
 
Chair: Ray J. Chiu & Sujit Banyatpiyaphod
 10.20 a.m.  Animal Model for Cell Therapy
 Masashi Komeda
, Kyoto University, Kyoto, Japan
 10.40 a.m.  Endothelial Progenitor Cell Culture and Gene Transfer
 Takayuki Asahara
, RIKEN Center for Developmental Biology, Kobe,  Japan
 
 11.00 a.m.  Maximizing Ventricular Function with Multimodal Cell-Based Gene  Therapy
 Silviu Itescu
, Columbia University, New York, USA
 
 11.20 a.m.  Cardiac Regenation by Cell Transplantation
 Richard D. Weisel
, Toronto General Hospital, Toronto, Canada
 11.40 a.m.  Stem cell for Myocardial Regeneration: Lessons Learned from the  Past
 Ray J.
Chiu, McGill University, Montreal, Canada
 
 12.00 p.m. – 1.00 p.m.  Lunch Symposium II
 Chair: Hermann C.
Reichenspurner & Rapin Kukreja

 Angiogenic Cell Precursors
 Yael
Porat, TheraVitae, Thailand
 
 1.00 p.m. – 2.10 p.m.  Plenary Session IV : Clinical Application and Results I
 
Chair: Mary Laughlin & Rapin Kukreja
 1.00 p.m.  Transcoronary Stem Cell Injection : Results of Intracoronary  Angiogenic Precursor Cells Injection in Cardiomyopathy
 Suphachai Chaithiraphan
, Choa Phraya Hospital , Bangkok ,  Thailand
 
 1.30 p.m.  Surgical Aspects of Stem Cell Delivery
 Kitipan
Arom, Bangkok  Heart Hospital , Bangkok, Thailand
 1.50 p.m.  Results of Intramyocardial Angiogenic Precursor Cells Injection in  Cardiomyopathy
 Permyos Ruengsakulrach
, Bangkok Heart Hospital , Bangkok,  Thailand
 
 2.10 p.m.  Coffee Break
 
 2.40 p.m. – 4.00 p.m.  Plenary Session V: Clinical Application and Results II
 Chair: Ren-Ke Li & Pradub Sukhum
 2.40 p.m.  An Actuarial View of Clinical Trial Statistics vs. the Real World
 Don
Margolis, Founder, Thera Vitae Holdings
 3.00 p.m.  The First Report Results of MAGIC TRIAL
 Hermann C.
Reichenspurner , University Hospital Eppendorf ,  Hamburg , Germany
 
 3.20 p.m.  Update Results of Skeletal Myoblast Transplantation
 Doris A.Taylor, University of Minnesota , Minneapolis , MN , USA
 3.40 p.m.  Autologous Intracoronary AC133 + Stem Cell Injection in Chronic  Ischemia: First Report from the SEACOAST Trial
 Mary Laughlin,
Case Western Reserve University , Cleveland , OH ,  USA
 
 4.00 p.m.  Adjourn
 6.30 p.m.  Cocktail Dinner by TheraVitae Limited, Thailand.
   
 Sunday, December 3, 2006
 9.00 a.m. – 12.00 p.m.  Registration Open
 8.00 a.m. – 10.00 a.m.  Plenary Session VI: Cell Recruitment/Evaluation and  Alternative Treatment
 Chair: Eugene
Sim & Vitoon Pitiguagool
 
 8.00 a.m.  Quantitative Analysis of Survival of Transplanted Cells
 Ren-Ke Li
, Toronto General Hospital , Toronto , Canada
 8.20 a.m.  Effects of Statins, Nitric Oxide and Antioxidation on Endothelium and  Endothelial Progenitor Cell Recruitment
 Takayuki Asahara
, RIKEN Center for Developmental Biology, Kobe ,  Japan
 
 8.40 a.m.  Chronic Effects of Transmyocardial Laser Revascularization in the  Nonischemic Myocardium
 Eugene Sim
, National University Singapore , Singapore
 
 9.00 a.m.
 Surgical Ventricular Volume Reduction for Dilated Cardiomyopathy  Masashi Komeda, Kyoto University , Japan
 9.20 a.m.  Any Evidence- Based Available for CABG Alone or CABG+CELL Work  in End-Stage Heart Failure
 Kitipan Arom,
Bangkok Heart Hospital , Bangkok, Thailand
 
 9.40 a.m.  Heart Transplantation and Surgical Alternatives
 Hermann C.
Reichenspurner , University Hospital Eppendorf ,  Hamburg , Germany
 
 10.00 a.m.  Discussion
 10.20 a.m.  Coffee Break
 10.40 a.m. – 11.40 a.m.  Selected Poster Presentation: A Rapid Firing Session
 Chair: Ray J.
Chiu & Kitipan Arom
 11.40 a.m. – 12.30 p.m.  Lunch Symposium III
 Chair:
Sudaratana Tansuphaswadikul
           &
Chumpol Supanantaroek
 The role of BNP in the Management of Heart Failure
 
Pradub Sukhum , Bangkok Heart Hospital, Bangkok
 
 12.30 p.m. – 3.00 p.m.  Plenary Session VII: Future Lies Ahead
 Chair: Kriengchai Prasongsukarn & Richard D. Weisel
 12.30 p.m.  Blood-Borne Stem Cell
 Valentin Fulga
, TheraVitae, BKK
 12.50 p.m.  Myoblast
 Kristic Comella,
, Bioheart, Inc. Sunrise FL. USA
 1.10 p.m.  Cord Blood
 Kostas I. Papadopoulos
, StemLife, BKK, Thailand
 1.30 p.m.  Bone Marrow
 Silviu
Itescu , Columbia University , New York , USA
 1.50 p.m.  Tissue Engineering
 Richard D. Weisel
, Toronto General Hospital , Toronto , Canada
 2.10 p.m.  Discussion
 3.00 p.m.  Closing: Kitipan Arom
Adjourn
   
   
 
TheraVitae